As many as 70 million people in the United States grapple with constant sleeping issues, a troubling statistic that has sparked new research into the implications of inadequate sleep on health. Doctors universally recommend that adults get at least seven hours of quality sleep each night to maintain optimal health. However, failing to reach this benchmark can significantly increase an individual's risk of health concerns, including cognitive decline and dementia.
A groundbreaking study published in Nature Medicine has unveiled that the risk of developing dementia after the age of 55 among Americans has more than doubled compared to previous estimates. This revelation underscores the critical importance of understanding the mechanics of sleep and its role in brain health, as the glymphatic system—responsible for removing "waste" linked to neurodegenerative diseases—operates primarily during sleep.
The study highlights the intricate dance of synchronized oscillations during sleep that energize the brain’s glymphatic system, facilitating the removal of waste. Conducted using a mouse model, this research has profound implications for our understanding of the relationship between sleep and neurodegenerative diseases. Norepinephrine, a neuromodulator crucial in this process, is released in slow cycles approximately every 50 seconds during non-REM sleep, helping regulate the constriction of arteries and enhancing waste removal.
“Sleep allows the brain to go offline, shut down processing of the external world and focus on maintenance tasks, such as immune surveillance and removal of waste.” – Natalie Hauglund, PhD
Despite significant advances in sleep research, a unified explanation for why humans need sleep remains elusive, even as we approach 2025. The rhythmic nature of sleep and its stages have been studied extensively, yet scientists continue to probe deeper into its mysteries.
“In the year 2025, there remains no accepted response on why we sleep. Different researchers make different claims and sometimes these are the same and sometimes they are different. We know healthy sleep makes us healthy and poor sleep makes us unhealthy.” – Segil
The study also raises concerns about the use of sleep aids. These medications can block the neuromodulators that drive the brain's waste removal system, potentially impairing its ability to prepare effectively for a new day.
“Sleep is crucial as it gives the brain time to perform homeostatic housekeeping tasks such as waste removal. On the contrary, sleep aids block the neuromodulators that drive the waste removal system and prevent the brain [from] properly preparing for a new day.”
Peter G. Polos, MD, PhD, highlights the importance of continued research in this area, noting that alterations in this delicate balance could have cellular and perhaps clinical consequences.
“This study suggests that alterations in this tight balance have potential cellular and perhaps clinical consequences. While fascinating, we must remind ourselves that this is an animal study and, as is often the case, extrapolation of animal data to humans must be done cautiously. Nonetheless, it does give clinicians a phenomenon that is deserving of some discussion.” – Peter G. Polos, MD, PhD, FCCP, FAASM
The findings open new doors for exploring how sleep aids affect human glymphatic flow and emphasize the need for more comprehensive studies.
“If more work were to be done in this area, we certainly would like to see if studies could assess the impact of sleep aids on human glymphatic flow.” – Peter G. Polos, MD, PhD, FCCP, FAASM
Meanwhile, Maiken Nedergaard, MD, PhD, points out a unique aspect of human biology: unlike other systems in the body that rely on lymphatic vessels to remove waste products such as dead cells and bacteria, the brain depends on its glymphatic system.
“Our brain is unique in that it does not have lymphatic vessels, which removes waste products such as dead cells and bacteria from the rest of our body.” – Maiken Nedergaard, MD, PhD
Despite debates surrounding the potential adverse effects of sleep aids like zolpidem on REM sleep and subsequent neurotransmitter levels in the brain, some experts remain unconcerned.
“It is extremely unlikely the benefits of increased sleep which occurs when patients use a sleep aid like zolpidem are outweighed by any claimed potential adverse effect of this medication decreasing REM sleep, which then in turn decreases brain neurotransmitter levels, [which] then in turn decreases brain protein levels,” – Segil
“Clinical neurologists like me are not concerned [that] using zolpidem appropriately in elderly patients who can’t sleep will cause dementia.” – Segil
Leave a Reply